Literature DB >> 21176785

Neuroinflammation modulates distinct regional and temporal clinical responses in ALS mice.

David R Beers1, Weihua Zhao, Bing Liao, Osamu Kano, Jinghong Wang, Ailing Huang, Stanley H Appel, Jenny S Henkel.   

Abstract

An inflammatory response is a pathological hallmark of amyotrophic lateral sclerosis (ALS), a relentless and devastating degenerative disease of motoneurons. This response is not simply a late consequence of motoneuron degeneration, but actively contributes to the balance between neuroprotection and neurotoxicity; initially infiltrating lymphocytes and microglia slow disease progression, while later, they contribute to the acceleration of disease. Since motor weakness begins in the hindlimbs of ALS mice and only later involves the forelimbs, we determined whether differential protective versus injurious inflammatory responses in the cervical and lumbar spinal cords explained the temporally distinct clinical disease courses between the limbs of these mice. Densitometric evaluation of immunohistochemical sections and quantitative RT-PCR (qRT-PCR) demonstrated that CD68 and CD11c were differentially increased in their spinals cords. qRT-PCR revealed that protective and anti-inflammatory factors, including BDNF, GDNF, and IL-4, were increased in the cervical region compared with the lumbar region. In contrast, the toxic markers TNF-α, IL-1β and NOX2 were not different between ALS mice cervical and lumbar regions. T lymphocytes were observed infiltrating lumbar spinal cords of ALS mice prior to the cervical region; mRNA levels of the transcription factor gata-3 (Th2 response) were differentially elevated in the cervical cord of ALS mice whereas t-bet (Th1 response) was increased in the lumbar cord. These results reinforce the important balance between specific protective/injurious inflammatory immune responses in modulating clinical outcomes and suggest that the delayed forelimb motor weakness in ALS mice is partially explained by augmented protective responses in the cervical spinal cords.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21176785      PMCID: PMC3096756          DOI: 10.1016/j.bbi.2010.12.008

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


  59 in total

Review 1.  Macrophage activation and polarization.

Authors:  Fernando Oneissi Martinez; Antonio Sica; Alberto Mantovani; Massimo Locati
Journal:  Front Biosci       Date:  2008-01-01

2.  Local self-renewal can sustain CNS microglia maintenance and function throughout adult life.

Authors:  Bahareh Ajami; Jami L Bennett; Charles Krieger; Wolfram Tetzlaff; Fabio M V Rossi
Journal:  Nat Neurosci       Date:  2007-11-18       Impact factor: 24.884

Review 3.  Microglia: active sensor and versatile effector cells in the normal and pathologic brain.

Authors:  Uwe-Karsten Hanisch; Helmut Kettenmann
Journal:  Nat Neurosci       Date:  2007-11       Impact factor: 24.884

4.  Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities.

Authors:  S R McKercher; B E Torbett; K L Anderson; G W Henkel; D J Vestal; H Baribault; M Klemsz; A J Feeney; G E Wu; C J Paige; R A Maki
Journal:  EMBO J       Date:  1996-10-15       Impact factor: 11.598

5.  Brain-derived neurotrophic factor supports facial motoneuron survival after facial nerve transection in immunodeficient mice.

Authors:  Craig J Serpe; Susanna C Byram; Virginia M Sanders; Kathryn J Jones
Journal:  Brain Behav Immun       Date:  2005-03       Impact factor: 7.217

6.  Aberrant RNA processing in a neurodegenerative disease: the cause for absent EAAT2, a glutamate transporter, in amyotrophic lateral sclerosis.

Authors:  C L Lin; L A Bristol; L Jin; M Dykes-Hoberg; T Crawford; L Clawson; J D Rothstein
Journal:  Neuron       Date:  1998-03       Impact factor: 17.173

7.  CNS-derived interleukin-4 is essential for the regulation of autoimmune inflammation and induces a state of alternative activation in microglial cells.

Authors:  Eugene D Ponomarev; Katarzyna Maresz; Yanping Tan; Bonnie N Dittel
Journal:  J Neurosci       Date:  2007-10-03       Impact factor: 6.167

8.  Mutant SOD1(G93A) microglia are more neurotoxic relative to wild-type microglia.

Authors:  Qin Xiao; Weihua Zhao; David R Beers; Albert A Yen; Wenjie Xie; Jenny S Henkel; Stanley H Appel
Journal:  J Neurochem       Date:  2007-06-07       Impact factor: 5.372

9.  Immune surveillance in the injured nervous system: T-lymphocytes invade the axotomized mouse facial motor nucleus and aggregate around sites of neuronal degeneration.

Authors:  G Raivich; L L Jones; C U Kloss; A Werner; H Neumann; G W Kreutzberg
Journal:  J Neurosci       Date:  1998-08-01       Impact factor: 6.167

10.  Selective ablation of proliferating microglial cells exacerbates ischemic injury in the brain.

Authors:  Mélanie Lalancette-Hébert; Geneviève Gowing; Alain Simard; Yuan Cheng Weng; Jasna Kriz
Journal:  J Neurosci       Date:  2007-03-07       Impact factor: 6.167

View more
  79 in total

1.  Transformation from a neuroprotective to a neurotoxic microglial phenotype in a mouse model of ALS.

Authors:  Bing Liao; Weihua Zhao; David R Beers; Jenny S Henkel; Stanley H Appel
Journal:  Exp Neurol       Date:  2012-06-23       Impact factor: 5.330

2.  A conceptual revolution in the relationships between the brain and immunity.

Authors:  Michal Schwartz; Jonathan Kipnis
Journal:  Brain Behav Immun       Date:  2010-12-25       Impact factor: 7.217

Review 3.  Immune-mediated mechanisms in the pathoprogression of amyotrophic lateral sclerosis.

Authors:  Weihua Zhao; David R Beers; Stanley H Appel
Journal:  J Neuroimmune Pharmacol       Date:  2013-07-25       Impact factor: 4.147

4.  Microglia induce motor neuron death via the classical NF-κB pathway in amyotrophic lateral sclerosis.

Authors:  Ashley E Frakes; Laura Ferraiuolo; Amanda M Haidet-Phillips; Leah Schmelzer; Lyndsey Braun; Carlos J Miranda; Katherine J Ladner; Adam K Bevan; Kevin D Foust; Jonathan P Godbout; Phillip G Popovich; Denis C Guttridge; Brian K Kaspar
Journal:  Neuron       Date:  2014-03-05       Impact factor: 17.173

5.  Evaluation of regulatory T lymphocytes and IL2Ra and FOXP3 gene expression in peripheral mononuclear cells from patients with amyotrophic lateral sclerosis.

Authors:  Sara Rashid Chehreh Bargh; Abbas Tafakhori; Farimah Masoumi; Farzaneh Rahmani; Mona Ahmadi; Afshin Namdar; Maryam Azimi; Parsova Tavasolian; Sima Habibi; Babak Zamani; Marziyeh Maserrat; Maryam Sadr; Farshid Noorbakhsh; Nima Rezaei
Journal:  Ir J Med Sci       Date:  2018-03-25       Impact factor: 1.568

6.  Immunological aspects in amyotrophic lateral sclerosis.

Authors:  Maria Carolina O Rodrigues; Júlio C Voltarelli; Paul R Sanberg; Cesario V Borlongan; Svitlana Garbuzova-Davis
Journal:  Transl Stroke Res       Date:  2012-05-03       Impact factor: 6.829

Review 7.  Mesenchymal Stromal Cell Therapies for Neurodegenerative Diseases.

Authors:  Nathan P Staff; David T Jones; Wolfgang Singer
Journal:  Mayo Clin Proc       Date:  2019-05       Impact factor: 7.616

8.  Clemastine Confers Neuroprotection and Induces an Anti-Inflammatory Phenotype in SOD1(G93A) Mouse Model of Amyotrophic Lateral Sclerosis.

Authors:  Savina Apolloni; Paola Fabbrizio; Chiara Parisi; Susanna Amadio; Cinzia Volonté
Journal:  Mol Neurobiol       Date:  2014-12-09       Impact factor: 5.590

9.  The Neurotoxic TAU45-230 Fragment Accumulates in Upper and Lower Motor Neurons in Amyotrophic Lateral Sclerosis Subjects.

Authors:  Claudia R Vintilescu; Sana Afreen; Ashlee E Rubino; Adriana Ferreira
Journal:  Mol Med       Date:  2016-08-03       Impact factor: 6.354

10.  Macrophage-mediated inflammation and glial response in the skeletal muscle of a rat model of familial amyotrophic lateral sclerosis (ALS).

Authors:  Jonathan M Van Dyke; Ivy M Smit-Oistad; Corey Macrander; Dan Krakora; Michael G Meyer; Masatoshi Suzuki
Journal:  Exp Neurol       Date:  2016-01-13       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.